
Phase 3 success for allergy drug
Aldeyra Therapeutics has announced positive results from the Phase 3 ALLEVIATE Trial of reproxalap topical ophthalmic solution in patients with allergic conjunctivitis. "This confirms the potential

Aldeyra Therapeutics has announced positive results from the Phase 3 ALLEVIATE Trial of reproxalap topical ophthalmic solution in patients with allergic conjunctivitis. "This confirms the potential

A Queensland University of Technology PhD student working to prevent diabetes-related blindness in Indigenous communities is the inaugural winner of a new Queensland Women in STEM award

New research led by the Centre for Eye Research Australia will test the effectiveness of an artificial intelligence (AI)-based technology in providing much-needed eye screening services in remote and

Alnylam and Regeneron announced they have joined forces in a multi-million dollar deal to discover, develop and commercialise new gene-regulating drugs including some aimed at combating eye

Combining smart contact lenses with smart glasses could prevent or lessen eye strain and make virtual reality (VR) solutions a practical option for everyday use, VR developer Innovega said in a white

An NIH study has found there is no evidence that calcium increases the risk of age-related macular degeneration (AMD).The findings contradict an earlier study indicating that high levels of calcium

Arkansas has become the fourth US state to allow optometrists to perform certain laser procedures, behind Oklahoma, Kentucky and Louisiana. The bill allows optometrists in the state to perform new

A contact lens designed for visual correction has been shown to deliver antihistamine to treat allergy as effectively as directly administering a topical drug, according to a study published in

We’re seeing more exciting news from spring and summer collections released in the Northern hemisphere, plus we’re delighted to introduce the new optical range by Le Specs and Etnia Barcelona and Fatheadz, which have both found new homes with new New Zealand distributors.

University of Liverpool researchers have published a new study in PLOS ONE, highlighting the high incidence and prevalence of visual problems in acute stroke survivors, which are currently often under-reported by survivors.

The New Zealand Myopia Action Group (NZMAG) says a proposed bill “will limit the prescription of non-approved medicines to only medical practitioners, preventing community optometrists prescribing

A handheld gaming device designed by UK and Auckland-based researchers to rebalance amblyopic children’s vision has been approved as a medical device in the UK.